At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003
In Brief
An observational study for Myelodysplastic Syndrome. Completed, enrolled 54 participants across 15 sites in 2 countries.
Detailed Summary
Multi-center, survival data collection in subjects previously enrolled in study NCT00065156 (Celgene Protocol CC-5013-MDS-003).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMyelodysplastic Syndrome
CountriesGermany, United States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2010
First PostedApr 2010
Primary CompletionOct 2010
TodayJul 2026
First PostedApr 6, 2010
Enrollment StartMar 1, 2010
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 16.2 years ago